Trump Approves Nvidia AI Chip Sales to China

US President Donald Trump has said that he will permit “authorized clients” in China to purchase Nvidia’s cutting-edge H200 processors. On social media on Monday, Trump declared, “We will preserve National Security, generate American Jobs, and retain America’s lead in AI.” Following intensive lobbying by Nvidia CEO Jensen Huang, who traveled to Washington last week … Read more

IndiGo Faces Governance Heat After Operational Collapse

Sell-side downgrades, increased target-price dispersion, and growing governance concerns are starting to show that the market is no longer viewing IndiGo’s early-December flight disruption—the airline’s worst operational breakdown in years—as a temporary scheduling shock. IndiGo Faces Compliance Lapses Between December 5 and 8, at least five institutional analysts changed their positions, with global firms like … Read more

IndiGo Regrets Flight Chaos, Cites Unforeseen Operational Issues

In response to the aviation safety regulator DGCA’s show cause letters about the airline’s significant flight interruptions, IndiGo CEO Pieter Elbers and COO Isidre Porqueras have submitted responses. The airline’s two senior executives had until Monday at six of the clock to respond to the notifications. IndiGo has expressed “profuse” regret to the passengers impacted … Read more

Recursion Pharma Surges on FAP Trial Results; Market Update Highlights

Following favorable Phase 2 trial findings for its investigational medication REC-4881 in familial adenomatous polyposis (FAP), a rare hereditary illness for which there are no licensed treatments, Recursion Pharmaceuticals’ (NASDAQ:RXRX) shares increased 7% on Monday. Strong Clinical Results Reported According to the business, REC-4881 showed quick clinical action, with a 43% median decrease in total … Read more